Desq Long
Sign in
SEC FORM 4
—

Latigo Biotherapeutics, Inc. (LTGO)

Acquisition (code C) of 2,350,419 shares; price not stated (see filing).

Reporting Persons 5AM Ventures VI, L.P. · 5AM Partners VI, LLC · 5AM Opportunities II, L.P. · 5AM Opportunities II (GP), LLC · PARMAR KUSH · Schwab Andrew J. · Transaction Code C

Traded Aug 10, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001231919-26-000869 · filed 2026-08-12 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Latigo Biotherapeutics, Inc. (LTGO)." Disclosed 2026-08-12. https://desqlong.com/cards/0001231919-26-000869-2 (retrieved 2026-09-26).